In Trade War, China’s Chokehold on US Medicine Moves Into Spotlight

featured-image

China's iron grip on supply of critical drug ingredients has been years in the making, driven by Beijing's strategic plan to dominate the pharma industry

WASHINGTON—As the COVID-19 pandemic swept across the globe in 2020, hospitals across the United States found themselves scrambling for masks, gloves, and other critical medical supplies.The crisis served as a wake-up call for the United States, despite being a global leader in the pharmaceutical industry. Politicians and health care leaders vowed to fix the dangerous overreliance on foreign-made medical supplies, a problem that had gone largely unnoticed.

Fast forward a few years and not much has changed, Michael Einhorn, founder of Dealmed, a medical supply distributor based in New York, told The Epoch Times.In March 2020, Einhorn witnessed what he called the “logistical nightmare” firsthand when shipments from China ground to a halt..



...